SCHEMBL8204074

SCHEMBL8204074

C1=NC2=CCCNC2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24506481 0.61
SCHEMBL2503843 0.56
Hydrochloric Acid SCHEMBL17606644 0.55
SCHEMBL18230868 0.55
SCHEMBL27485944 0.52
SCHEMBL9966682 0.52
SCHEMBL1550826 0.52
SCHEMBL1364578 0.52
SCHEMBL2218606 0.51
Bromide SCHEMBL28296934 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103736-A SHOWING AN INHIBITORY ACTION ON GASTRIC ACID SECRETION AND A PROTECTIVE ACTION OF GASTRIC MUCOSA; 2-(HETERO)ARYL-3-AMINOIMIDAZO-(2,1-A)ISOQUINOLINES; ANTIULCER AGENTS; SHINNIPPON PHARMACEUTICAL INC. (JP) 2000-08-15 US disclosed
US-6020342-A Fused imidazo[1,2-A]pyridines SHINNIPPON PHARMACEUTICAL, INC. (JP) 2000-02-01 US disclosed
EP-0822194-A1 FUSED IMIDAZO 1,2-a]PYRIDINES Shinnippon Pharmaceutical Inc. (JP) 1998-02-04 EP disclosed